Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Recurrence × Transplantation × Clear all

Phase

Status

Completed 4 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia 6 Leukemia, Myeloid, Acute 5 Myelodysplastic Syndromes 4 Lymphoma 4 Lymphoma, Non-Hodgkin 3 Graft vs Host Disease 3 Congenital Abnormalities 3 Anemia, Refractory, with Excess of Blasts 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Multiple Myeloma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Recurrence 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myeloid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hematologic Neoplasms 1 Genetic Diseases, Inborn 1 Burkitt Lymphoma 1 Blast Crisis 1 Anemia, Aplastic 1

Interventions

Dexamethasone 29 Cyclophosphamide 21 Rituximab 17 Cytarabine 16 Bortezomib 13 Gemcitabine 12 fludarabine 11 Methotrexate 11 Lenalidomide 10 Filgrastim 10 Vincristine 9 pomalidomide 8 pembrolizumab 8 Paclitaxel 8 Etoposide 8 Azacitidine 8 venetoclax 7 carfilzomib 7 Doxorubicin 7 Docetaxel 7 Cyclosporine 7 Calcium Dobesilate 7 Antilymphocyte Serum 7 fludarabine phosphate 6 Topotecan 6 Temozolomide 6 Radiotherapy 6 Peripheral Blood Stem Cell Transplantation 6 Mitoxantrone 6 daratumumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01578343 2016-04-15

ZOLINZA

Samsung Medical Center

Phase 2 Terminated

Recurrence, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡